Cargando…

Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

BACKGROUND: Endothelial cell activation and dysfunction are the foundation of atherosclerosis, including coronary artery disease (CAD). Endothelial cell activation is mediated by the level of gene transcription. Early growth response 3 (Egr3) is a critical determinant of vascular endothelial growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Ma, Yi-Tong, Xie, Xiang, Yang, Yi-Ning, Ma, Xiang, Zheng, Ying-Ying, Pan, Shuo, Liu, Fen, Chen, Bang-Dang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040484/
https://www.ncbi.nlm.nih.gov/pubmed/24886494
http://dx.doi.org/10.1186/1476-511X-13-84
_version_ 1782318578488311808
author Li, Xia
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Ma, Xiang
Zheng, Ying-Ying
Pan, Shuo
Liu, Fen
Chen, Bang-Dang
author_facet Li, Xia
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Ma, Xiang
Zheng, Ying-Ying
Pan, Shuo
Liu, Fen
Chen, Bang-Dang
author_sort Li, Xia
collection PubMed
description BACKGROUND: Endothelial cell activation and dysfunction are the foundation of atherosclerosis, including coronary artery disease (CAD). Endothelial cell activation is mediated by the level of gene transcription. Early growth response 3 (Egr3) is a critical determinant of vascular endothelial growth factor (VEGF) signalling in activated endothelial cells. If endothelial cells are excessively activated, it may lead to vasculopathic diseases, such as pathologic angiogenesis, inflammation, and atherosclerosis. The aim of the present study was to assess the association between the Egr3 gene polymorphisms and CAD. METHODS: Two independent case–control studies that involved the Han group (409 CAD patients and 351 control subjects) and the Uygur group (299 CAD patients and 303 control subjects) analysed the relationship between Egr3 SNPs (rs1996147 and rs1008949) and CAD. Genotyping was undertaken using the TaqMan SNP genotyping assay. RESULTS: The entire Uygur group and the males in the Uygur group showed a higher frequency of the A allele (rs1996147) in CAD patients than in the control subjects (P = 0.003 and P = 0.005, respectively). Additionally, the distribution of the recessive model of rs1996147 (AA vs GG + AG) for the total sample and the males was significantly different between CAD patients and control participants (P = 0.002 and P = 0.003, respectively), and the difference remained statistically significant following multivariate adjustment (Total: OR = 1.705; 95% CI: 1.166-2.494, P = 0.006; males: OR = 1.908, 95% CI: 1.189-3.062, P = 0.007). However, for Uygur females, we did not observe a difference in the allele frequency or genotypic distribution of rs1996147 between CAD patients and control participants. Similarly, the distribution of the rs1996147 allele frequency or genotypes showed no significant difference between patients with CAD and control participants in the Han group. The distribution of rs1008949 genotypes, dominant model, recessive model, and allele frequency did not show a significant difference between patients with CAD and the control subjects in the Han and Uygur groups. CONCLUSION: rs1996147 may be a novel polymorphism of the Egr3 gene associated with CAD in males of the Chinese Uygur population.
format Online
Article
Text
id pubmed-4040484
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40404842014-06-03 Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China Li, Xia Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Ma, Xiang Zheng, Ying-Ying Pan, Shuo Liu, Fen Chen, Bang-Dang Lipids Health Dis Research BACKGROUND: Endothelial cell activation and dysfunction are the foundation of atherosclerosis, including coronary artery disease (CAD). Endothelial cell activation is mediated by the level of gene transcription. Early growth response 3 (Egr3) is a critical determinant of vascular endothelial growth factor (VEGF) signalling in activated endothelial cells. If endothelial cells are excessively activated, it may lead to vasculopathic diseases, such as pathologic angiogenesis, inflammation, and atherosclerosis. The aim of the present study was to assess the association between the Egr3 gene polymorphisms and CAD. METHODS: Two independent case–control studies that involved the Han group (409 CAD patients and 351 control subjects) and the Uygur group (299 CAD patients and 303 control subjects) analysed the relationship between Egr3 SNPs (rs1996147 and rs1008949) and CAD. Genotyping was undertaken using the TaqMan SNP genotyping assay. RESULTS: The entire Uygur group and the males in the Uygur group showed a higher frequency of the A allele (rs1996147) in CAD patients than in the control subjects (P = 0.003 and P = 0.005, respectively). Additionally, the distribution of the recessive model of rs1996147 (AA vs GG + AG) for the total sample and the males was significantly different between CAD patients and control participants (P = 0.002 and P = 0.003, respectively), and the difference remained statistically significant following multivariate adjustment (Total: OR = 1.705; 95% CI: 1.166-2.494, P = 0.006; males: OR = 1.908, 95% CI: 1.189-3.062, P = 0.007). However, for Uygur females, we did not observe a difference in the allele frequency or genotypic distribution of rs1996147 between CAD patients and control participants. Similarly, the distribution of the rs1996147 allele frequency or genotypes showed no significant difference between patients with CAD and control participants in the Han group. The distribution of rs1008949 genotypes, dominant model, recessive model, and allele frequency did not show a significant difference between patients with CAD and the control subjects in the Han and Uygur groups. CONCLUSION: rs1996147 may be a novel polymorphism of the Egr3 gene associated with CAD in males of the Chinese Uygur population. BioMed Central 2014-05-21 /pmc/articles/PMC4040484/ /pubmed/24886494 http://dx.doi.org/10.1186/1476-511X-13-84 Text en Copyright © 2014 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Xia
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Ma, Xiang
Zheng, Ying-Ying
Pan, Shuo
Liu, Fen
Chen, Bang-Dang
Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_full Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_fullStr Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_full_unstemmed Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_short Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_sort association of egr3 genetic polymorphisms and coronary artery disease in the uygur and han of china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040484/
https://www.ncbi.nlm.nih.gov/pubmed/24886494
http://dx.doi.org/10.1186/1476-511X-13-84
work_keys_str_mv AT lixia associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT mayitong associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT xiexiang associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT yangyining associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT maxiang associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT zhengyingying associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT panshuo associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT liufen associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT chenbangdang associationofegr3geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina